Amlodipine News and Research

RSS
Watson Laboratories receives FDA approval for Amlodipine capsules

Watson Laboratories receives FDA approval for Amlodipine capsules

EMA approves TWYNSTA therapy that reduces BP in hypertensive patients

EMA approves TWYNSTA therapy that reduces BP in hypertensive patients

Telmisartan and amlodipine combination therapy helps achieve high BP control/response rates

Telmisartan and amlodipine combination therapy helps achieve high BP control/response rates

FDA approves Novartis' Tekamlo for treatment of high blood pressure

FDA approves Novartis' Tekamlo for treatment of high blood pressure

Study examines comparative value of different blood pressure lowering medications

Study examines comparative value of different blood pressure lowering medications

Boehringer Ingelheim announces European CHMP Positive Opinion for TWYNSTA

Boehringer Ingelheim announces European CHMP Positive Opinion for TWYNSTA

Study results of triple combination therapy in patients with diabetes and hypertension presented at ADA 2010

Study results of triple combination therapy in patients with diabetes and hypertension presented at ADA 2010

Mylan-Nifedipine Extended Release tablets launched in Canada

Mylan-Nifedipine Extended Release tablets launched in Canada

Triple combination therapy with OM, AML, HCTZ more effective at lowering blood pressure

Triple combination therapy with OM, AML, HCTZ more effective at lowering blood pressure

Takeda announces submission of azilsartan medoxomil NDA for hypertension to FDA

Takeda announces submission of azilsartan medoxomil NDA for hypertension to FDA

Amlodipine benazepril capsules for treatment of hypertension launched in the US market

Amlodipine benazepril capsules for treatment of hypertension launched in the US market

Almost 62% of Canadians age 65 and older use five or more classes of prescription drugs: CIHI study

Almost 62% of Canadians age 65 and older use five or more classes of prescription drugs: CIHI study

Teva Pharmaceutical Industries announces fourth-quarter and full-year 2009 financial results

Teva Pharmaceutical Industries announces fourth-quarter and full-year 2009 financial results

FDA approves Lupin Pharmaceuticals' Amlodipine/Benazepril capsules

FDA approves Lupin Pharmaceuticals' Amlodipine/Benazepril capsules

Mylan first to file ANDA patent for Caduet Tablets

Mylan first to file ANDA patent for Caduet Tablets

AIIRA/CCB drug combination provides superior safety and efficacy compared to other fixed-dose combinations

AIIRA/CCB drug combination provides superior safety and efficacy compared to other fixed-dose combinations

Non-clinical data from Cytokinetics' smooth muscle contractility program presented

Non-clinical data from Cytokinetics' smooth muscle contractility program presented

HealthTrans Access sponsors 50 disadvantaged families to free healthcare support

HealthTrans Access sponsors 50 disadvantaged families to free healthcare support

Teva Pharmaceutical Industries net sales up 25%

Teva Pharmaceutical Industries net sales up 25%

Boehringer Ingelheim's TWYNSTA approved by FDA for the treatment of hypertension

Boehringer Ingelheim's TWYNSTA approved by FDA for the treatment of hypertension